I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 25 studies | 35% ± 17% | |
| glutamatergic neuron | 10 studies | 42% ± 25% | |
| oligodendrocyte precursor cell | 10 studies | 30% ± 13% | |
| astrocyte | 10 studies | 32% ± 15% | |
| microglial cell | 8 studies | 31% ± 12% | |
| endothelial cell of lymphatic vessel | 8 studies | 39% ± 20% | |
| GABAergic neuron | 8 studies | 46% ± 23% | |
| oligodendrocyte | 7 studies | 30% ± 11% | |
| pericyte | 6 studies | 22% ± 7% | |
| interneuron | 6 studies | 47% ± 24% | |
| macrophage | 6 studies | 32% ± 6% | |
| epithelial cell | 6 studies | 30% ± 16% | |
| neuron | 5 studies | 39% ± 14% | |
| ciliated cell | 5 studies | 22% ± 7% | |
| type I pneumocyte | 5 studies | 26% ± 9% | |
| granule cell | 4 studies | 26% ± 4% | |
| retinal ganglion cell | 4 studies | 31% ± 13% | |
| capillary endothelial cell | 4 studies | 36% ± 13% | |
| cardiac muscle cell | 4 studies | 19% ± 2% | |
| monocyte | 4 studies | 23% ± 1% | |
| club cell | 4 studies | 23% ± 8% | |
| fibroblast | 4 studies | 24% ± 7% | |
| smooth muscle cell | 4 studies | 19% ± 1% | |
| type II pneumocyte | 4 studies | 21% ± 7% | |
| GABAergic interneuron | 3 studies | 35% ± 5% | |
| CD4-positive, alpha-beta T cell | 3 studies | 17% ± 0% | |
| dendritic cell | 3 studies | 17% ± 2% | |
| vein endothelial cell | 3 studies | 42% ± 25% | |
| GABAergic amacrine cell | 3 studies | 24% ± 10% | |
| amacrine cell | 3 studies | 26% ± 15% | |
| glycinergic amacrine cell | 3 studies | 22% ± 4% | |
| endothelial cell of vascular tree | 3 studies | 45% ± 22% | |
| hepatocyte | 3 studies | 45% ± 22% | |
| abnormal cell | 3 studies | 33% ± 13% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 24% ± 7% | |
| T cell | 3 studies | 21% ± 4% | |
| alveolar macrophage | 3 studies | 30% ± 6% | |
| lymphocyte | 3 studies | 31% ± 12% | |
| basal cell | 3 studies | 35% ± 21% | |
| transit amplifying cell | 3 studies | 37% ± 27% |
